247 related articles for article (PubMed ID: 834147)
1. Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.
Ferrari C; Frezzati S; Romussi M; Bertazzoni A; Testori GP; Antonini S; Paracchi A
Metabolism; 1977 Feb; 26(2):129-39. PubMed ID: 834147
[TBL] [Abstract][Full Text] [Related]
2. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
Ferrari C; Testori GP; Bertazzoni A; Romussi M; Caldara R; Frezzati S
Horm Metab Res; 1978 Jan; 10(1):4-6. PubMed ID: 631736
[TBL] [Abstract][Full Text] [Related]
3. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
[TBL] [Abstract][Full Text] [Related]
4. Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia.
Feldman EB; Gluck FB; Carter AC
J Clin Pharmacol; 1978; 18(5-6):241-8. PubMed ID: 346616
[TBL] [Abstract][Full Text] [Related]
5. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
[TBL] [Abstract][Full Text] [Related]
6. Effect of clofibrate on glucose tolerance in maturity onset diabetes.
Barnett D; Craig JG; Robinson DS; Rogers MP
Br J Clin Pharmacol; 1977 Aug; 4(4):455-8. PubMed ID: 901737
[TBL] [Abstract][Full Text] [Related]
7. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.
Agata J; Miyazaki Y; Takada M; Murakami H; Masuda A; Miura T; Ura N; Shimamoto K
Hypertens Res; 1998 Mar; 21(1):57-62. PubMed ID: 9582109
[TBL] [Abstract][Full Text] [Related]
8. Variation of blood glucose and serum growth hormone, prolactin and insulin in subjects with insulin-dependent diabetes, after OGTT and pretreatment with 2-Br-alpha-ergocryptine.
Gnudi A; Lugari R; Cavazzini MG
Acta Diabetol Lat; 1977; 14(3-4):119-28. PubMed ID: 343464
[TBL] [Abstract][Full Text] [Related]
9. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
Schwandt P; Weisweiler P; Neureuther G; Wilkening J
MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
[TBL] [Abstract][Full Text] [Related]
10. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
[TBL] [Abstract][Full Text] [Related]
11. The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease.
Enger SC; Johnsen V; Samuelsen A; Laws EA
Acta Med Scand; 1977; 201(6):563-6. PubMed ID: 327758
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of clofibrate on arginine-induced insulin secretion in chemical diabetes.
Pontiroli AE; Viberti G; Pozza G
Acta Diabetol Lat; 1976; 13(3-4):107-10. PubMed ID: 1020607
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
14. Investigation of insulin sensitivity in early diabetes III. The effect of a combined physical training and diet programme on body weight, serum lipids and insulin sensitivity in obese asymptomatic diabetics.
Ratzmann KP; Zander E; Witt S; Schulz B
Endokrinologie; 1981 Apr; 77(2):233-41. PubMed ID: 7262046
[TBL] [Abstract][Full Text] [Related]
15. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.
Carrascosa JM; Molero JC; Fermín Y; Martínez C; Andrés A; Satrústegui J
Diabetes Obes Metab; 2001 Aug; 3(4):240-8. PubMed ID: 11520303
[TBL] [Abstract][Full Text] [Related]
17. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
[No Abstract] [Full Text] [Related]
18. [Glucocorticoid-induced hypertiglyceridemia: effects of cortisone acetate on triglyceride secretion rates and post-heparin lipolytic activity in rabbits (author's transl)].
Mibayashi Y
Nihon Naibunpi Gakkai Zasshi; 1978 Mar; 54(3):203-18. PubMed ID: 206474
[TBL] [Abstract][Full Text] [Related]
19. Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study.
Kobayashi M; Shigeta Y; Hirata Y; Omori Y; Sakamoto N; Nambu S; Baba S
Diabetes Care; 1988 Jun; 11(6):495-9. PubMed ID: 3042317
[TBL] [Abstract][Full Text] [Related]
20. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
